Barriers to the widespread adoption of diagnostic artificial intelligence for preventing antimicrobial resistance

阻碍诊断人工智能在预防抗菌素耐药性方面得到广泛应用的障碍

阅读:2

Abstract

Currently, antimicrobial resistance (AMR) poses a major public health challenge. The emergence of AMR, which significantly threatens public health, is primarily due to the overuse of antimicrobial agents. This study explored the possibility that the ethical dilemmas inherent in the context of AMR may hinder the adoption of diagnostic artificial intelligence (AI). We conducted a web survey across eight countries/areas to assess public preference between two hypothetical AI types: one prioritizing individual health and the other considering the global AMR threat. Our results revealed a societal preference for the utilization of both AI types, reflecting a conflict between recognizing the significance of AMR and the desire for individualized treatment. Interestingly, the survey indicated significant gender and age differences in AI preferences, and the majority of respondents opposed the idea of AI standardization in treatment. These findings highlight the challenges of incorporating AI into public health and the necessity of considering public sentiment in addressing global health issues such as AMR.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。